Blockskye | $15,800,000 | (Jul 18, 2025)
Occupi | $3,000,000 | (Jul 18, 2025)
Receive | $4,000,000 | (Jul 18, 2025)
Certified by Founder
Lodge
Delphia Therapeutics
start up
United States
- Cambridge, Massachusetts
- 07/05/2024
- Series A
- $67,000,000
Delphia Therapeutics is a biotechnology company pioneering activation lethality, a new area of cancer therapeutics that target cancer's surprising vulnerability to oncogene overactivation. Delphia’s activation lethality platform offers the potential for first-in-class targeted cancer medicines that are effective on their own while also combating the emergence of drug resistance to classic targeted therapies.
- Industry Biotechnology Research
- Website https://www.delphiatx.com/
- LinkedIn https://www.linkedin.com/company/delphia-therapeutics/
Empirical Security | $12,000,000 | (Jul 18, 2025)
WattCarbon | Undisclosed Amount | (Jul 18, 2025)
StrongestLayer | $5,200,000 | (Jul 18, 2025)
Folio | $14,000,000 | (Jul 18, 2025)
Lo Foods | $3,500,000 | (Jul 18, 2025)
BQP(US) | $5,000,000 | (Jul 18, 2025)
TRIFFT Loyalty | $550,000 | (Jul 18, 2025)
One Biosciences | $17,382,375 | (Jul 17, 2025)
KNOT(INDIA) | $3,000,000 | (Jul 17, 2025)